Bacterial colicin-immunity protein protein purification system
US-2024417426-A1 · Dec 19, 2024 · US
US11932891B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11932891-B2 |
| Application number | US-202017439600-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 31, 2020 |
| Priority date | Apr 1, 2019 |
| Publication date | Mar 19, 2024 |
| Grant date | Mar 19, 2024 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The subject invention provides microbe-based products and efficient methods of producing them. In specific embodiments, methods are provided for enhanced production of microbial biosurfactants, the methods comprising co-cultivating Myxococcus xanthus and Bacillusamyloliquefaciens. In preferred embodiments, co-cultivation is carried out continuously for an indefinite period of time. Microbe-based products produced according to the subject methods are also provided, as well as their uses in, for example, agriculture, oil and gas recovery, and health care.
Opening claim text (preview).
The invention claimed is: 1. A method for enhanced production of one or more microbial growth by-products, the method comprising co-cultivating a first microorganism and a second microorganism in a fermentation reactor, wherein the first microorganism is a myxobacterium and the second microorganism is B. amyloliquefaciens NRRL B-67928, and wherein a greater concentration of the one or more microbial growth by-products is achieved than would be achieved if the first and second microorganisms were cultivated individually. 2. The method of claim 1 , wherein the myxobacterium is a Myxococcus spp. 3. The method of claim 2 , wherein the Myxococcus is M. xanthus. 4. The method of claim 1 , wherein the one or more growth by-products are biosurfactants. 5. The method of claim 4 , wherein the biosurfactants are lipopeptides. 6. The method of claim 5 , wherein the lipopeptides are surfactin, iturin and/or fengycin. 7. The method of claim 5 , wherein the biosurfactants are glycolipids and/or fatty acid esters. 8. The method of claim 1 , wherein a greater cell biomass is achieved for the first and/or second microorganism than if the first and second microorganisms were cultivated separately. 9. The method of claim 1 , wherein co-cultivating the first and the second microorganisms comprises: inoculating the fermentation reactor with the first microorganism and inoculating the fermentation reactor with the second microorganism, wherein the fermentation reactor comprises a liquid nutrient medium; incubating the first and second microorganisms under conditions favorable for growth and production of the one or more microbial growth by-products; extracting the one or more growth by-products from the reactor; collecting the one or more growth by-products in a collection container; and, optionally, purifying the one or more growth by-products. 10. The method of claim 9 , wherein the liquid nutrient medium comprises a particulate anchoring carrier suspended therein as a site for nucleating microbial growth. 11. The method of claim 9 , carried out continuously for 1 week or longer, wherein the one or more growth by-products are extracted and collected on a consistent basis, and wherein the liquid nutrient medium is continuously replenished. 12. The method of claim 9 , wherein the one or more growth by-products are produced in the form of a foam layer. 13. The method of claim 1 , wherein the first microorganism stimulates enhanced production of the one or more growth by-products by the second microorganism. 14. The method of claim 1 , wherein the growth by-products are produced at a concentration that is at least 0.01% to at least 90% greater than if the first or the second microorganisms were cultivated separately.
having a known sequence of two or more amino acids, e.g. glutathione · CPC title
Bacteria; Culture media therefor · CPC title
Processes using foam culture · CPC title
Fatty acid esters · CPC title
Preparation of compounds containing saccharide radicals (ketoaldonic acids C12P7/58) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.